Centro Médico Teknon
Radiotherapy for breast cancer in Spain typically costs from $5,000 to $10,000. The final price depends on the technology used, number of sessions, and clinic location. Patients save around 81% compared to the US, where this treatment costs $40,000 on average. Fees usually cover consultations, treatment planning scans, radiation sessions, and follow-up care.
Bookimed Expert Insight: Choosing a high-volume center in Spain offers significant clinical value. Centro Médico Teknon in Barcelona is JCI-accredited and handles 10,000 patients annually. Its prestige attracts global figures, yet it maintains high-quality standards found in top US hospitals. GenesisCare Clinics provides access to a global network of 300 centers. This ensures patients receive standardized, world-class radiotherapy protocols across their Madrid facilities.
Why choose Spain for radiotherapy for breast cancer?
Access advanced Radiotherapy for breast cancer solutions in trusted clinics .
| Turkey | Austria | Spain | |
| Radiotherapy for breast cancer | from $4,500 | from $10,000 | from $5,000 |
Day 1
Day 2 - 3
Day 4 - 5
Week 2 - 6
Week 7
Week 8 - 12
Week 13 - 16
Please note that the timeline and procedures may vary based on the individual patient"s condition and response to treatment.
The doctor is a pediatric oncologist with 37 years of experience, specializing in the treatment of blood disorders and performing procedures like bone marrow transplants and ablation therapy. The doctor is currently the Head of Paediatric Haemato-Oncology at Quironsalud Madrid University Hospital.
With a prolific academic record, the doctor has edited 14 books, contributed to 75 book chapters, and presented at over 200 conferences. The doctor is a member of several professional associations, including the Spanish Association of Paediatric Haematology and the Spanish Association of Paediatric Oncology.
The doctor treats a wide range of conditions, including leukemia, lymphoma, multiple myeloma, and various hematological and autoimmune disorders.
The doctor is an experienced oncologist recognized for successful breast cancer treatments. He holds an MBBS from University Autónoma de Barcelona and completed his residency at Clinic Vall d'Hebron. He conducted significant research on telomerase in New York.
He is the head of the breast cancer program at HM Delfos and leads Oncology services at Clin del Mar in Spain. As the director of the cancer research program at Del Mar, he is a prominent member of GEICAM, CIBERONC, AIECA, and SEOM. The doctor has published 120 articles in reputable journals, amassing over 9000 citations.